These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3096356)

  • 21. Interleukin-1 beta, -6 and interferon-gamma productions in patients undergoing continuous ambulatory peritoneal dialysis.
    Choi KH; Lee IH; Shin SK; Noh HJ; Kang SW; Lee HY; Han DS
    Yonsei Med J; 1998 Jun; 39(3):240-6. PubMed ID: 9664829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limitations of peritoneal dialysis.
    Ronco C
    Kidney Int Suppl; 1996 Nov; 56():S69-74. PubMed ID: 8914057
    [No Abstract]   [Full Text] [Related]  

  • 23. Serial peritoneal macrophage function studies in CAPD patients with peritonitis.
    Lin CY; Huang TP
    Adv Perit Dial; 1990; 6():114-9. PubMed ID: 1982786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory function in CAPD.
    Di Paolo N; Pula G; Buoncristiani U; Giomarelli PP; DeMia M; Biagioli B; Zei E; Bernini M
    Int J Artif Organs; 1984 Mar; 7(2):67-72. PubMed ID: 6735498
    [No Abstract]   [Full Text] [Related]  

  • 25. Progress of peripheral uremic neuropathy during continuous ambulatory peritoneal dialysis (CAPD).
    Lindholm B; Tegnér R; Tranaeus A; Bergström J
    Trans Am Soc Artif Intern Organs; 1982; 28():263-9. PubMed ID: 6298985
    [No Abstract]   [Full Text] [Related]  

  • 26. Longitudinal changes of peritoneal function calculated by personal dialysis capacity in a patient after long-term continuous ambulatory peritoneal dialysis.
    Nakamoto H; Takane H; Sugahara S; Kanno Y; Okada H; Yamamoto T; Suzuki H
    Adv Perit Dial; 2003; 19():97-102. PubMed ID: 14763042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptomatic accidental introduction of disinfectant electrolytic chloroxidizer solution into the peritoneal cavity of CAPD patients. Incidence and long-term effects on ultrafiltration.
    De Vecchi AF; Castelnovo C; Scalamogna A; Paparella M
    Clin Nephrol; 1992 Apr; 37(4):204-8. PubMed ID: 1316248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peritoneal rest may successfully recover ultrafiltration in patients who develop peritoneal hyperpermeability with time on continuous ambulatory peritoneal dialysis.
    Rodrigues A; Cabrita A; Maia P; Guimarães S
    Adv Perit Dial; 2002; 18():78-80. PubMed ID: 12402593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential role for interleukin-1 in fibrosis associated with chronic ambulatory peritoneal dialysis.
    Krane SM; Goldring MB
    Blood Purif; 1988; 6(3):173-7. PubMed ID: 3134927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis.
    Shioshita K; Miyazaki M; Ozono Y; Abe K; Taura K; Harada T; Koji T; Taguchi T; Kohno S
    Kidney Int; 2000 Feb; 57(2):619-31. PubMed ID: 10652040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrafiltration failure and dialysate glucose in CAPD.
    Stegmayr B; Granbom L; Karlsson UM; Lindqvist B
    Adv Perit Dial; 1993; 9():62-4. PubMed ID: 8105964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A low CA++ level in effluent as a risk factor for the peritonitis in CAPD patients.
    Suga H; Honda H; Naganuma S; Yashuo M; Suzuki T; Teraoka S; Agishi T; Ota K
    Adv Perit Dial; 1990; 6():102-5. PubMed ID: 1982783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nutritional aspects and problems in the uremic patient under CAPD].
    Viglino G; Mariano F; Bollo P; Vallone P; Servetti L; Goia F; Cavalli PL
    Minerva Urol Nefrol; 1986; 38(2):183-9. PubMed ID: 3750160
    [No Abstract]   [Full Text] [Related]  

  • 34. Intraperitoneal verapamil therapy in CAPD patients with peritoneal hypopermeability. Effects on ultrafiltration.
    Lamperi S; Carozzi S; Nasini MG; Canepa M; Zanin T
    ASAIO Trans; 1988; 34(3):425-8. PubMed ID: 3196541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow up of the thyroid function in patients (pts) in treatment with C.A.P.D.
    Checchia G; Querques M; Ktena M; Tappi A; D'Amato V
    Life Support Syst; 1985; 3 Suppl 1():131-6. PubMed ID: 3870553
    [No Abstract]   [Full Text] [Related]  

  • 36. Contrasting changes in solute transport and ultrafiltration with peritonitis in CAPD patients.
    Raja RM; Kramer MS; Rosenbaum JL; Bolisay C; Krug M
    Trans Am Soc Artif Intern Organs; 1981; 27():68-70. PubMed ID: 7331156
    [No Abstract]   [Full Text] [Related]  

  • 37. [Peritoneal dialysis-- 60-year anniversary and expansion through CAPD].
    Grefberg N; Nilsson P
    Nord Med; 1983; 98(11):260-2. PubMed ID: 6361687
    [No Abstract]   [Full Text] [Related]  

  • 38. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients.
    Moutabarrik A; Nakanishi I; Namiki M; Tsubakihara Y
    Clin Nephrol; 1995 Apr; 43(4):243-8. PubMed ID: 7606878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Continuous ambulatory peritoneal dialysis (CAPD). An alternative possibility for patients with terminal uremia].
    Knudsen T; Brinch E; Clausen E; Hagen K; Ostergaard O
    Ugeskr Laeger; 1985 Dec; 148(1):8-11. PubMed ID: 4095793
    [No Abstract]   [Full Text] [Related]  

  • 40. [Alternative procedures in the therapy of chronic uremia (hemofiltration, continuing ambulatory peritoneal dialysis)].
    Scheler F
    Verh Dtsch Ges Inn Med; 1981; 87():1405-8. PubMed ID: 7331435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.